HINGE HEALTH INC-A (HNGE) Fundamental Analysis & Valuation

NYSE:HNGE • US4333131039

Current stock price

44.76 USD
+0.2 (+0.45%)
At close:
44.69 USD
-0.07 (-0.16%)
Pre-Market:

This HNGE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HNGE Profitability Analysis

1.1 Basic Checks

  • HNGE had negative earnings in the past year.
  • HNGE had a positive operating cash flow in the past year.
HNGE Yearly Net Income VS EBIT VS OCF VS FCFHNGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • HNGE has a Return On Assets of -84.92%. This is amonst the worse of the industry: HNGE underperforms 93.00% of its industry peers.
  • HNGE has a Return On Equity of -167.07%. This is in the lower half of the industry: HNGE underperforms 78.00% of its industry peers.
Industry RankSector Rank
ROA -84.92%
ROE -167.07%
ROIC N/A
ROA(3y)-25.36%
ROA(5y)N/A
ROE(3y)-46.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNGE Yearly ROA, ROE, ROICHNGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • With an excellent Gross Margin value of 79.65%, HNGE belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
  • HNGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNGE Yearly Profit, Operating, Gross MarginsHNGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. HNGE Health Analysis

2.1 Basic Checks

  • HNGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HNGE has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for HNGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HNGE Yearly Shares OutstandingHNGE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 20M 40M 60M
HNGE Yearly Total Debt VS Total AssetsHNGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.44 indicates that HNGE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.44, HNGE is in line with its industry, outperforming 56.00% of the companies in the same industry.
  • There is no outstanding debt for HNGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.44
ROIC/WACCN/A
WACC8.94%
HNGE Yearly LT Debt VS Equity VS FCFHNGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • HNGE has a Current Ratio of 1.47. This is a normal value and indicates that HNGE is financially healthy and should not expect problems in meeting its short term obligations.
  • HNGE's Current ratio of 1.47 is in line compared to the rest of the industry. HNGE outperforms 56.00% of its industry peers.
  • A Quick Ratio of 1.43 indicates that HNGE should not have too much problems paying its short term obligations.
  • The Quick ratio of HNGE (1.43) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.43
HNGE Yearly Current Assets VS Current LiabilitesHNGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HNGE Growth Analysis

3.1 Past

  • HNGE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -4978.69%.
  • HNGE shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.58%.
EPS 1Y (TTM)-4978.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%362.94%
Revenue 1Y (TTM)50.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.27%

3.2 Future

  • Based on estimates for the next years, HNGE will show a very strong growth in Earnings Per Share. The EPS will grow by 21.18% on average per year.
  • HNGE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.73% yearly.
EPS Next Y30.48%
EPS Next 2Y24.96%
EPS Next 3Y24.15%
EPS Next 5Y21.18%
Revenue Next Year28.01%
Revenue Next 2Y23.19%
Revenue Next 3Y21.67%
Revenue Next 5Y19.73%

3.3 Evolution

HNGE Yearly Revenue VS EstimatesHNGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
HNGE Yearly EPS VS EstimatesHNGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. HNGE Valuation Analysis

4.1 Price/Earnings Ratio

  • HNGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 23.19, the valuation of HNGE can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as HNGE.
  • HNGE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.88.
Industry RankSector Rank
PE N/A
Fwd PE 23.19
HNGE Price Earnings VS Forward Price EarningsHNGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HNGE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.32
EV/EBITDA N/A
HNGE Per share dataHNGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HNGE's earnings are expected to grow with 24.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.96%
EPS Next 3Y24.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HNGE Dividend Analysis

5.1 Amount

  • No dividends for HNGE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HNGE Fundamentals: All Metrics, Ratios and Statistics

HINGE HEALTH INC-A

NYSE:HNGE (4/22/2026, 8:04:00 PM)

Premarket: 44.69 -0.07 (-0.16%)

44.76

+0.2 (+0.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)05-05
Inst Owners95.22%
Inst Owner Change0.35%
Ins Owners3.54%
Ins Owner Change-22.31%
Market Cap3.53B
Revenue(TTM)587.86M
Net Income(TTM)-632.43M
Analysts82.61
Price Target59.42 (32.75%)
Short Float %8.67%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.05%
Min EPS beat(2)21.95%
Max EPS beat(2)92.15%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.61%
Min Revenue beat(2)6.37%
Max Revenue beat(2)6.86%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.54%
PT rev (3m)-8.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)30.4%
EPS NY rev (1m)0%
EPS NY rev (3m)23.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.28%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)4.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.19
P/S 6
P/FCF 21.32
P/OCF 20.56
P/B 9.31
P/tB 11.3
EV/EBITDA N/A
EPS(TTM)-13.84
EYN/A
EPS(NY)1.93
Fwd EY4.31%
FCF(TTM)2.1
FCFY4.69%
OCF(TTM)2.18
OCFY4.86%
SpS7.46
BVpS4.81
TBVpS3.96
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -84.92%
ROE -167.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.65%
FCFM 28.13%
ROA(3y)-25.36%
ROA(5y)N/A
ROE(3y)-46.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 118.14%
Cap/Sales 1.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.43
Altman-Z 2.44
F-Score6
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)87.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4978.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%362.94%
EPS Next Y30.48%
EPS Next 2Y24.96%
EPS Next 3Y24.15%
EPS Next 5Y21.18%
Revenue 1Y (TTM)50.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.27%
Revenue Next Year28.01%
Revenue Next 2Y23.19%
Revenue Next 3Y21.67%
Revenue Next 5Y19.73%
EBIT growth 1Y-2136.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.5%
EBIT Next 3Y29.26%
EBIT Next 5Y28.82%
FCF growth 1Y265.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y249.87%
OCF growth 3YN/A
OCF growth 5YN/A

HINGE HEALTH INC-A / HNGE Fundamental Analysis FAQ

What is the fundamental rating for HNGE stock?

ChartMill assigns a fundamental rating of 3 / 10 to HNGE.


What is the valuation status of HINGE HEALTH INC-A (HNGE) stock?

ChartMill assigns a valuation rating of 3 / 10 to HINGE HEALTH INC-A (HNGE). This can be considered as Overvalued.


How profitable is HINGE HEALTH INC-A (HNGE) stock?

HINGE HEALTH INC-A (HNGE) has a profitability rating of 1 / 10.


How financially healthy is HINGE HEALTH INC-A?

The financial health rating of HINGE HEALTH INC-A (HNGE) is 6 / 10.